Real Good Food Company Voluntarily Removes Nasdaq Listing
Rhea-AI Filing Summary
Real Good Food Company, Inc. (RGF) filed a Form 25 with the SEC to remove its Class A common stock from listing and registration on the Nasdaq Stock Market under Section 12(b) of the Exchange Act.
The notice, signed by Nasdaq on 23 June 2025, confirms that both the exchange and the issuer fulfilled the requirements of 17 CFR 240.12d2-2(b) & (c). Once effective, the shares will no longer trade on Nasdaq, and registration under Section 12(b) will be withdrawn. Investors should anticipate a transition to over-the-counter quotation or another venue, which typically leads to reduced liquidity, higher transaction costs and diminished market visibility.
Positive
- None.
Negative
- Class A common stock removed from Nasdaq listing, reducing market liquidity and visibility.
- Loss of exchange-level governance and disclosure standards, increasing risk for minority shareholders.
Insights
TL;DR: Nasdaq delisting of RGF is materially negative, curbing liquidity and signaling elevated risk.
The Form 25 filing formalizes the removal of Real Good Food Company’s Class A shares from Nasdaq. Delisting eliminates the regulatory and visibility benefits of a national exchange, which usually compresses daily trading volume, widens bid-ask spreads and limits institutional ownership. Although the company describes the withdrawal as voluntary and compliant, investors face higher execution costs and potential valuation pressure once trading migrates to the OTC market. The action is therefore impactful and negative for existing shareholders.
TL;DR: Voluntary delisting raises governance concerns and may reduce shareholder protections.
Exchange listing imposes ongoing governance, disclosure and audit standards. By exiting Nasdaq, RGF will be subject to less stringent OTC requirements. This diminishes transparency, complicates shareholder engagement and may increase the company’s cost of capital. Unless accompanied by a go-private transaction, minority investors bear the downside of weaker oversight without clear compensating benefits. The filing therefore carries negative governance implications.